Table 3.
Uncontrolleda | IGH-IV 2019 and ESC/ESH 2018 | ACC/AHA 2017 | ||||
---|---|---|---|---|---|---|
Men (n=9148a; n=9070b) | Women (n=5244a; n=5148b) | Total (n=14,398a; n=14,254b) | Men (n=5244a; n=5148b) | Women (n=5244a; n=5148b) | Total (n=14,398a; n=14,254b) | |
SBP | 72.7 (6655) | 69.3 (3632) | 71.5 (10,287) | 88.8 (8123) | 86.5 (4538) | 88.0 (12,661) |
DBP | 68.0 (6167) | 65.6 (3399) | 67.1 (9566) | 93.7 (8495) | 91.9 (4764) | 93.0 (13,259) |
Notes: Data presented as % (n). aTotal number of patients with available SBP values;bTotal number of patients with available DBP values: uncontrolled SBP defined as SBP ≥140 mmHg (IGH-IV and ESC/ESH) and SBP ≥130 mmHg (ACC/AHA); uncontrolled DBP defined as DBP ≥90 mmHg (IGH-IV and ESC/ESH) and SBP ≥80 mmHg (ACC/AHA).
Abbreviations: ACC/AHA, American College of Cardiology (ACC) and American Heart Association (AHA);ESC/ESH, European Society of Cardiology (ESC) and European Society of Hypertension (ESH); IGH-IV, Indian Guideline on Hypertension-IV.